Essex Investment Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Essex Investment Management’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-47,169	Closed	-$507K	–	441
2022 Q3	$507K	Sell	47,169 -3,236	-6%	-$36.7K	0.08%	240
2022 Q2	$604K	Buy	50,405 +18,365	+57%	+$296K	0.1%	239
2022 Q1	$686K	Buy	32,040 +777	+2%	+$20.6K	0.09%	249
2021 Q4	$1.05M	Buy	31,263 +6,471	+26%	+$180K	0.12%	223
2021 Q3	$638K	Buy	+24,792	New	+$443K	0.08%	251
2019 Q2	–	Sell	-22,987	Closed	-$302K	–	522
2019 Q1	$302K	Sell	22,987 -26,950	-54%	-$393K	0.04%	306
2018 Q4	$722K	Buy	+49,937	New	+$814K	0.11%	231

Other funds holding OPNT

WSL

Western Standard LLC Los Angeles, California $295M AUM 40.98% 1-Year Est. Return

ACA

Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NYLIM

New York Life Investment Management New York $14.3B AUM 34.42% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Ramius Advisors New York $95.2M AUM 7.33% 1-Year Est. Return

Essex Investment Management's OPNT Position: Q4 2022 in Review

Essex Investment Management sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q4 2022, closing a stake of 47,169 shares — an estimated $507K sold.

Essex Investment Management first reported a position in OPNT in Q4 2018 and held it in 7 quarters. The position peaked at $1.05M in Q4 2021. 37 funds tracked by Wall St. Rank hold OPNT as of Q4 2022.

Essex Investment Management reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Essex Investment Management sold 47,169 Opiant Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $507K.
Essex Investment Management first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 7 quarters.
Essex Investment Management's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $1.05M in Q4 2021.
37 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Essex Investment Management's 13F filing for Q4 2022, filed 3 Feb 2023.